MitoCareX Bio Completes Initial Computational Drug Screening Stage
MitoCareX Bio says it completed the initial computational screening stage of its AI-driven drug discovery initiative with Boltz.
MitoCareX Bio says it completed the initial computational screening stage of its AI-driven drug discovery initiative with Boltz.